Switch theme
Sign up to access all valuation multiples
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
1937
17.3K+
LTM Revenue $4.6B
LTM EBITDA $1.1B
$13.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Smith & Nephew has a last 12-month revenue of $4.6B and a last 12-month EBITDA of $1.1B.
In the most recent fiscal year, Smith & Nephew achieved revenue of $7.5B and an EBITDA of $1.6B.
Smith & Nephew expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Smith & Nephew valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $7.1B | $7.5B | XXX | XXX | XXX |
| Gross Profit | $4.7B | $4.9B | XXX | XXX | XXX |
| Gross Margin | 66% | 66% | XXX | XXX | XXX |
| EBITDA | $1.2B | $1.6B | XXX | XXX | XXX |
| EBITDA Margin | 17% | 21% | XXX | XXX | XXX |
| Net Profit | $287M | $339M | XXX | XXX | XXX |
| Net Margin | 4% | 5% | XXX | XXX | XXX |
| Net Debt | $3.0B | $3.3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Smith & Nephew's stock price is GBP 10 (or $13).
Smith & Nephew has current market cap of GBP 8.5B (or $11.0B), and EV of GBP 10.6B (or $13.7B).
See Smith & Nephew trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13.7B | $11.0B | XXX | XXX | XXX | XXX | $0.88 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Smith & Nephew has market cap of $11.0B and EV of $13.7B.
Smith & Nephew's trades at 2.3x LTM EV/Revenue multiple, and 9.3x LTM EBITDA.
Analysts estimate Smith & Nephew's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Smith & Nephew and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $13.7B | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 8.7x | XXX | XXX | XXX |
| P/E | 20.7x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 17.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSmith & Nephew's NTM/LTM revenue growth is 2%
Smith & Nephew's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Smith & Nephew's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Smith & Nephew's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Smith & Nephew and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 28% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 23% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 39% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 55% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Smith & Nephew acquired XXX companies to date.
Last acquisition by Smith & Nephew was XXXXXXXX, XXXXX XXXXX XXXXXX . Smith & Nephew acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Smith & Nephew founded? | Smith & Nephew was founded in 1937. |
| Where is Smith & Nephew headquartered? | Smith & Nephew is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Smith & Nephew have? | As of today, Smith & Nephew has 17.3K+ employees. |
| Who is the CEO of Smith & Nephew? | Smith & Nephew's CEO is Mr. Deepak S. Nath. |
| Is Smith & Nephew publicy listed? | Yes, Smith & Nephew is a public company listed on LON. |
| What is the stock symbol of Smith & Nephew? | Smith & Nephew trades under SN. ticker. |
| When did Smith & Nephew go public? | Smith & Nephew went public in 1951. |
| Who are competitors of Smith & Nephew? | Similar companies to Smith & Nephew include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Smith & Nephew? | Smith & Nephew's current market cap is $11.0B |
| What is the current revenue of Smith & Nephew? | Smith & Nephew's last 12-month revenue is $4.6B. |
| What is the current EBITDA of Smith & Nephew? | Smith & Nephew's last 12-month EBITDA is $1.1B. |
| What is the current EV/Revenue multiple of Smith & Nephew? | Current revenue multiple of Smith & Nephew is 2.3x. |
| What is the current EV/EBITDA multiple of Smith & Nephew? | Current EBITDA multiple of Smith & Nephew is 9.3x. |
| What is the current revenue growth of Smith & Nephew? | Smith & Nephew revenue growth between 2023 and 2024 was 5%. |
| Is Smith & Nephew profitable? | Yes, Smith & Nephew is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
